What are the graft survival rates and overall success rates for hair transplantation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hair Transplant Success Rates

Modern hair transplantation using follicular unit techniques achieves graft survival rates of approximately 85-93% at one year, with the highest quality evidence showing 82.7% survival at 7-12 months that progressively declines over time.

Graft Survival Rates by Timeframe

The most recent systematic review 1 provides the clearest longitudinal data on follicular unit graft survival:

  • 7-12 months: 82.7% (peak survival period)
  • 13-24 months: 73.3%
  • 25-36 months: 58.4%
  • 37-48 months: 55.4%
  • 49-72 months: 39.6%

This progressive decline demonstrates that transplanted hair grafts do not necessarily last permanently for all patients 2, contradicting the common assumption of permanent results.

Success Rates by Technique and Alopecia Type

Non-Scarring Alopecia (Androgenetic Alopecia)

A comprehensive meta-analysis 3 shows:

  • Micrografts alone: 84.98% survival (95% CI 78.90-91.06)
  • Micrografts + minigrafts: 93.11% survival (95% CI 91.93-94.29)
  • Patient satisfaction: 89.70-97.00%

Scarring Alopecia (Primary Cicatricial Alopecia)

For inactive PCA 1, 3:

  • Micrografts: 88.66% survival (95% CI 80.12-97.20)
  • Micrografts + minigrafts: 86.25% survival (95% CI 74.00-98.50)
  • Patient satisfaction: 88.70-97.80%

Critical caveat: Four patients developed disease reactivation after transplantation in scarring alopecia 1, making patient selection crucial.

Technique Comparison: FUE vs. FUT

Contrary to earlier concerns, follicular unit extraction (FUE) grafts demonstrate equivalent survival to strip harvesting (FUT) 4. A controlled study showed:

  • FUT grafts: 94% follicular survival
  • FUE grafts: 109% survival (accounting for multiple hairs per follicle)

This equivalence is important as FUE is less invasive and avoids linear donor scarring.

Factors Affecting Long-Term Survival

Recipient Site Influence

The recipient site significantly affects transplanted hair characteristics 5:

  • Hair transplanted to non-scalp sites (e.g., leg) showed only 60.2% survival at 3 years
  • Growth rate decreased to 8.2 mm/month (vs. 16.0 mm/month on scalp)
  • Hair retransplanted back to scalp regained normal characteristics

This demonstrates that recipient site biology influences graft survival, not just donor dominance.

Adjunctive Therapies

Recent guidelines 6 suggest that platelet-rich fibrin (PRF) may improve graft retention/survival when used as:

  • Pre-treatment 7 days prior to surgery
  • Soaking medium for follicles during surgery

The evidence shows "substantial early hair regrowth" at 6 months with PRF augmentation, though specific survival rate improvements are not quantified.

Common Pitfalls to Avoid

  1. Overpromising permanence: Counsel patients that graft density may decline over years, with moderate reduction occurring in 55.35% of patients by 4 years 2

  2. Ignoring recipient site factors: Transplanting to non-scalp areas or severely compromised scalp may yield lower survival rates 5

  3. Operating on active scarring alopecia: Ensure disease is inactive for at least 12-24 months before considering transplantation to avoid reactivation 1

  4. Poor candidate selection: Not all hair loss conditions are suitable for transplantation 7

Optimizing Outcomes

The most recent expert consensus 8 emphasizes standardized perioperative procedures across 7 domains:

  • Preoperative preparation
  • Graft harvest technique
  • External dissection and trimming
  • Graft preservation protocols
  • Implantation technique
  • Postoperative care
  • Complication prevention

Each of these procedural elements directly impacts final graft survival rates, making technical excellence and protocol adherence essential for achieving results in the 85-93% range rather than the lower end of reported outcomes.

References

Research

A Systematic Review of Follicular Unit Graft Survival Rates After Hair Transplantation in Primary Cicatricial Alopecia.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2025

Research

Longevity of Hair Follicles after Follicular Unit Transplant Surgery.

Journal of cutaneous and aesthetic surgery, 2020

Research

[Singular graft's survival].

Georgian medical news, 2006

Research

Does the recipient site influence the hair growth characteristics in hair transplantation?

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002

Research

Hair transplantation: Basic overview.

Journal of the American Academy of Dermatology, 2021

Related Questions

Is a morning blood pressure of 105/54 mm Hg normal, and what management is recommended if the patient is asymptomatic?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What is the appropriate management for a 10‑month‑old infant with cough, wheezing, coarse breath sounds, and diarrhea?
What is the recommended evaluation and management for a 10-year-old male with pubic pain, intermittent dysuria for 2–3 months, decreased appetite, and urine specific gravity of 1.015?
What is the appropriate evaluation and management for a patient with a 0.5 cm round ground‑glass opacity in the right upper lung who has been exposed to chemicals and now presents with a chronic cough?
At what age do patients with Progressive Familial Intrahepatic Cholestasis type 1 (PFIC 1) and type 2 (PFIC 2) typically present?
A 30-year-old female with bilateral posterior foot white crusting and oozing blood—what is the diagnosis and appropriate treatment with dosages?
In a 22-year-old African-American male with elevated alanine aminotransferase (ALT 141 U/L) and aspartate aminotransferase (AST 57 U/L), negative hepatitis serology, normal abdominal ultrasound, and mild anemia (hemoglobin 12.8 g/dL, hematocrit 40.5 %), what is the appropriate next step for evaluating the liver enzyme elevation—further work‑up or watchful waiting?
What is the design, eligibility criteria, interventions, and outcomes of the CPReboa trial evaluating Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as an adjunct to standard cardiopulmonary resuscitation in adults with refractory non‑traumatic cardiac arrest?
What are the common causes of hair loss?
Why should the Coombs (direct antiglobulin) test be ordered in the evaluation of jaundice?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.